The endocannabinoid system: A novel player in human placentation.

Area of Science:

• Reproductive biology
• Pharmacology
• Developmental toxicology

Background:

• Cannabis sativa is globally prevalent, with consumption during pregnancy linked to fetal growth restriction.
• The endocannabinoid system (ECS), comprising endocannabinoids (eCBs) and cannabinoid receptors, regulates vital biological processes.
• Aberrant ECS expression is implicated in infertility and miscarriage, highlighting its reproductive significance.

Purpose of the Study:

• To review and discuss ECS expression in normal and pathological human placentas.
• To elucidate the role of eCBs and THC in trophoblast cell behavior (proliferation, apoptosis, differentiation, function).
• To understand the ECS contribution to human placentation and cannabis's adverse pregnancy effects.

Main Methods:

• Literature review and synthesis of existing research on ECS in human placentation.
• Analysis of studies investigating endocannabinoids and THC effects on trophoblast cells.
• Examination of ECS expression patterns in normal versus pathological placental tissues.

Main Results:

• Evidence suggests the ECS is integral to human placentation processes.
• Endocannabinoids (eCBs) contribute to the coordination of placental development.
• THC and eCBs influence key trophoblast functions, impacting placental health.

Conclusions:

• The endocannabinoid system (ECS) plays a crucial role in human placental development and function.
• Understanding ECS mechanisms is vital for addressing the negative impacts of prenatal cannabis exposure.
• Further research into ECS modulation may offer therapeutic avenues for pregnancy complications.